{
    "nctId": "NCT02746666",
    "briefTitle": "Pharmacist's Influence on Breast Cancer Patient Quality of Life",
    "officialTitle": "Influence of a Clinical Pharmacist's Intervention on Quality of Life of a Breast Cancer Patient Under Adjuvant Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Quality of Life",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 70,
    "primaryOutcomeMeasure": "changes in quality of life of a breast cancer patient under chemotherapy, after a clinical pharmacist's behavioral intervention, measured by EORTC B23 questionnaire",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Early breast cancer\n* First adjuvant chemotherapy\n* Chemotherapy protocol: anthracycline x 4\n\nExclusion Criteria:\n\n* Cardiovascular comorbidities\n* Regular nausea or vomiting during six months before enrollment\n* Unable to answer the quality of life questionnaire on their own",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}